Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | W.-J. Park, Int. J. of Mol. Medicine, 2016, 37:613-622; DOI: 10.3892/ijmm.2016.2461 | Link | ||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | R. Xu et al., Onkolgy Letters, 2018, 16: 439-446, DOI: 10.3892/ol.2018.8672 | Link | ||
Hep-G2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
Hepa 1-6 |
Mouse hepatoma cell line | ATCC CRL-1830 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | I. Kouskoumvekaki et al., J. Chem. Inf. Model., 2013, 53: 923−937, doi.org/10.1021/ci3006148 | ||
Hepa 1-6 |
Mouse hepatoma cell line | ATCC CRL-1830 | Mouse | digestive organs | cell line | adherent | plasmid | Metafectene | publication | K. Qvortrup et al., PLOSONE, 2017, DOI:10.1371/journal.pone.0162642 | Link | ||
Hepa-1c1c7 |
Mouse liver hepatoma cell line | ATCC CRL-2026 | Mouse | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | S. Surendran, PhD Thesis, 2014, Indiana University | |||
Hepa-1c1c7 |
Mouse liver hepatoma cell line | ATCC CRL-2026 | Mouse | digestive organs | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | Metafectene PRO | publication | S. Surendran et al., Scientific Reports, 2016, 6:18958; DOI: 10.1038/srep18958 | Link | |
Hepa-1c1c7 |
Mouse liver hepatoma cell line | ATCC CRL-2026 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | Metafectene PRO | publication | S. Surendran et al., Scientific Reports, 2016, 6:18958; DOI: 10.1038/srep18958 | Link | |
Hepa-1c1c7 |
Mouse liver hepatoma cell line | ATCC CRL-2026 | Mouse | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | S. Surendran, PhD Thesis, 2014, Indiana University | |||
hEPC |
Human endothelial progenitor cells | Human | other | primary cell | adherent | plasmid | Metafectene PRO | publication | G. Neumann, Dissertation, 2015, Georg-August-Universität zu Göttingen | Link | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | R. Montanari et a., Scientific Reports, 2016, 6: 27658, DOI: 10.1038/srep27658 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. I. Koukourakis et al., Investigational New Drugs, 2018, doi.org/10.1007/s10637-018-0566-0 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | M. Petrosino et al., Int. J. Mol. Sci., 2017, 18: 361-381 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | L. Siculella et al., Int. J. Mol. Sci., 2020, 21: 1206, doi:10.3390/ijms21041206 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | V. C. Sladky et al., Developmental Cell, 2020, 52: 335–349, doi.org/10.1016/j.devcel.2019.12.016 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | H.-S. Kwon et al., Diabetes, Apr 2004; 53: 899 - 910 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | F. Damiano et al., Bbamcb, 2018, doi.org/10.1016/j.bbalip.2018.01.006 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M.I. Koukourakis et al., Scientific Reports, 2016, 6:30986; DOI: 10.1038/srep30986 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. Prokesch et al., FASEB J., 2017, 31: 732-742 | Link |